Arkolith/Insider Trading/ENSC/Form 4

Wright Richard Chester

Chief Business OfficerEnsysce Biosciences, Inc. (ENSC) · full profile →Form 4 · filed Jul 2, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
0 non-derivative · 5 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2021Grant(A)66K——66K
Jun 30, 2021Grant(A)50K——50K
Jun 30, 2021Grant(A)988K——988K
Jun 30, 2021Grant(A)263K——263K
Jun 30, 2021Grant(A)20K——20K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001192482-21-000614) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML